Epigenica is a life science company headquartered in Solna, Sweden, that builds innovative products for epigenetic analysis. Backed by institutional investors like Almi Invest, the company develops research tools designed to foster scientific breakthroughs.
Subscribe to see Epigenica’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Epigenica is a biotechnology company headquartered in Sweden. Its most recent funding round, Seed, raised $2.2M in June 2025. Xcout tracks 3 named people at Epigenica, including Mohamad Takwa (CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2.2M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Epigenica's closest competitors — see the full list of competitors and alternatives →
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Pixelgen Technologies is a Swedish life-sciences company developing spatial proteomics technology that maps the location and interactions of proteins in and around individual cells. Its tools are intended for academic, biopharmaceutical, and biomedical researchers studying cell biology, immunology, and disease mechanisms.
KaRNAteq, Inc. develops advanced tools for RNA sequencing and licenses specialized reverse transcriptase technology representing the next step forward in genomics research.
Alithea Genomics is a Swiss biotechnology company headquartered in Cossonay, Switzerland. The firm delivers high-throughput transcriptomics kits and services to enable scalable RNA sequencing, gene expression profiling, and compound screening.
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Watchmaker Genomics, Inc. is a U.S. biotechnology company developing enzyme-based tools and workflows for genomics, including next-generation sequencing library preparation and related DNA/RNA analysis applications. It serves research, clinical, and biopharmaceutical users that need high-performance molecular biology and sequencing technologies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.